20 May 2013
Keywords: amira, dp2, blocker, track, ind, mid-2009, usa
Article | 12 January 2009
The USA's Amira Pharmaceuticals says that AM211, an internally-discovered oral drug candidate for the treatment and control
of inflammatory and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 January 2009
17 May 2013
© 2013 thepharmaletter.com